Arrowhead Research (ARWR), Genocea Biosciences (GNCA) will resume trading at 8:00am ET
- Japan's Nikkei posts biggest point gain for fiscal year
- Citi downgrades tech stocks as its flagship indicator signals 'euphoria' levels
- UBS sees 5 warnings signals on semiconductor chip stocks
- 2 reasons why Tesla stock fell on Thursday
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Cantor Fitzgerald Says Arrowhead Pharma's (ARWR) RNAi Deal with Amgen Validates Platform; Affirms at 'Buy'
September 29, 2016 10:49 AM EDTCantor Fitzgerald affirms Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) at Buy with a price target of $15 following its RNAi program collaboration agreement with Amgen (Nasdaq: AMGN).
The firm commented on Thursday, We believe the deal and its terms... More
Genocea Biosciences (GNCA),Arrowhead Research (ARWR) halted with news pending
September 29, 2016 7:26 AM EDTArrowhead Research (NASDAQ: ARWR) and Genocea Biosciences (NASDAQ: GNCA) trading halted with news pending.
... More